-

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of WestRock Company (WRK) Investigation

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of WestRock Company (“WestRock” or the “Company”) (NYSE: WRK). Investors who purchased WestRock securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/wrk.

The investigation concerns whether WestRock has violated federal securities laws.

On February 1, 2023, WestRock reported its first quarter financial and operating results. Among other items, WestRock reported earnings per share that missed analyst expectations by $0.05, as well as an unexpected year-over-year revenue decline that fell $210 million short of consensus estimates. WestRock attributed the disappointing results to “elevated inflation and softening macroeconomic conditions [which] negatively impacted [the Company’s] Global Paper business.” On this news, WestRock’s stock price fell $4.97 per share, or 12.67%, to close at $34.27 per share on February 1, 2023.

If you are aware of any facts relating to this investigation or purchased WestRock shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/wrk. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com

Bronstein, Gewirtz & Grossman, LLC

NYSE:WRK

Release Versions

Contacts

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com

More News From Bronstein, Gewirtz & Grossman, LLC

MGPI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MGP Ingredients, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MGP Ingredients, Inc. (“MGP Ingredients” or “the Company”) (NASDAQ: MGPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired...

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. (“Actinium” or “the Company”) (NYSE: ATNM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired...

TBBK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Bancorp, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Bancorp, Inc. (“Bancorp” or “the Company”) (NASDAQ: TBBK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Bancorp secu...
Back to Newsroom